Strides Arcolab has bought Aspen's ( south african company ) facility in Campos, Brazil, with related products and intellectual properties for about $75 million. It is an all-cash acquisition.
The facility makes Penems and Penicillins and has annual turnover of $40 million.
Strides Arcolabs is already operating in Brazil as Cellofarm with a manufacturing unit in the port city of Vitoria near Rio de Janeiro.
Strides has a manufacturing facility in Mexico City in the name of Solara and has a marketing & trading operation in Venezuela as Sumifarma.